• Users Online: 2783
  • Home
  • Print this page
  • Email this page

    Article Cited by others


Recent advances and challenges in the management of retinoblastoma

Chawla Bhavna, Singh Rashmi

Year : 2017| Volume: 65| Issue : 2 | Page no: 133-139

   This article has been cited by
1 Retinoblastoma: A review of the molecular basis of tumor development and its clinical correlation in shaping future targeted treatment strategies
Shruti Rathore, Aman Verma, Ria Ratna, Navjot Marwa, Yagya Ghiya, Santosh G Honavar, Anil Tiwari, Sima Das, Akhil Varshney
Indian Journal of Ophthalmology. 2023; 71(7): 2662
[Pubmed]  [Google Scholar] [DOI]
2 Identification of Epigenetically Modified Hub Genes and Altered Pathways Associated With Retinoblastoma
Aditi Karmakar, Md. Maqsood Ahamad Khan, Nidhi Kumari, Nalini Devarajan, Senthil Kumar Ganesan
Frontiers in Cell and Developmental Biology. 2022; 10
[Pubmed]  [Google Scholar] [DOI]
3 An in Vivo Study of Intravitreal Ranibizumab Following Subretinal Inoculation of Rb Cells In Rabbits’ Eyes
Nor Azimah Abd Aziz, Diana Toh Shi Jin, Tengku Ain Fathlun Tengku Kamalden, Sarina Sulung, Khairy Shamel Sonny Teo, Azhany Yaakub, Nor Hayati Othman, Liza-Sharmini Ahmad Tajudin
Czech and Slovak Ophthalmology. 2022; 78(3): 112
[Pubmed]  [Google Scholar] [DOI]
4 CircCUL2 suppresses retinoblastoma cells by regulating miR-214-5p/E2F2 Axis
Hui Zhang, XinWen Qiu, ZhiJie Song, LiXia Lan, Xuan Ren, Bo Ye
Anti-Cancer Drugs. 2022; 33(1): e218
[Pubmed]  [Google Scholar] [DOI]
5 TRIB3 promotes proliferation, migration, and invasion of retinoblastoma cells by activating the AKT/mTOR signaling pathway
Xian-Yi Bao, Ming Sun, Ting-Ting Peng, Dong-Mei Han
Cancer Biomarkers. 2021; 31(4): 307
[Pubmed]  [Google Scholar] [DOI]
6 Intraocular Tumors—Advances in Ophthalmic Pathology
Sneha Giridhar, Dipankar Das, Jyotirmay Biswas
Advances in Ophthalmology and Optometry. 2021; 6: 133
[Pubmed]  [Google Scholar] [DOI]
7 Long non-coding RNA SND1-IT1 accelerates cell proliferation, invasion and migration via regulating miR-132-3p/SMAD2 axis in retinoblastoma
Dong-Fang Yin, Xue-Jun Zhou, Na Li, Hui-Jie Liu, Hu Yuan
Bioengineered. 2021; 12(1): 1189
[Pubmed]  [Google Scholar] [DOI]
8 Therapeutic Targeting PLK1 by ON-01910.Na Is Effective in Local Treatment of Retinoblastoma
Huan Ma, Cong Nie, Ying Chen, Jinmiao Li, Yanjie Xie, Zhixin Tang, Yang Gao, Siming Ai, Yuxiang Mao, Qian Sun, Rong Lu
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 2021; 28(7): 745
[Pubmed]  [Google Scholar] [DOI]
9 Long non-coding RNA SNHG20 promotes cell proliferation, migration and invasion in retinoblastoma via the miR-335-5p/E2F3 axis
Jing Song, Ziping Zhang
Molecular Medicine Reports. 2021; 24(2)
[Pubmed]  [Google Scholar] [DOI]
10 Retinoblastoma brachytherapy (literature review)
E. S. Kotova, A. A. Yarovoy, D. P. Volodin, A. V. Kotelnikova
Russian Journal of Pediatric Hematology and Oncology. 2021; 8(1): 50
[Pubmed]  [Google Scholar] [DOI]
11 Long non-coding RNA LEF1-AS1 is involved in the progression of retinoblastoma through regulating the Wnt/ß-catenin pathway
Hua He, Mu Qin
Clinical and Experimental Pharmacology and Physiology. 2020; 47(5): 886
[Pubmed]  [Google Scholar] [DOI]
12 Intra-Arterial Chemotherapy for Retinoblastoma: Four-Year Results from Tertiary Center in India
Pukhraj Rishi, Ashutosh Agarwal, Pritam Chatterjee, Tarun Sharma, Minal Sharma, Munusamy Saravanan, R. Ravikumar
Ocular Oncology and Pathology. 2020; 6(1): 66
[Pubmed]  [Google Scholar] [DOI]
13 Clinical relevance of the comparative expression of immune checkpoint markers with the clinicopathological findings in patients with primary and chemoreduced retinoblastoma
Lata Singh, Mithalesh Kumar Singh, Moshahid Alam Rizvi, Sameer Bakhshi, Rachna Meel, Neiwete Lomi, Seema Sen, Seema Kashyap
Cancer Immunology, Immunotherapy. 2020; 69(6): 1087
[Pubmed]  [Google Scholar] [DOI]
14 LncRNA TMPO-AS1 up-regulates the expression of HIF-1a and promotes the malignant phenotypes of retinoblastoma cells via sponging miR-199a-5p
Xifeng Peng, Jian Yan, Fang Cheng
Pathology - Research and Practice. 2020; 216(4): 152853
[Pubmed]  [Google Scholar] [DOI]
15 Gold nanoparticles in ophthalmology
Florence Masse, Mathieu Ouellette, Guillaume Lamoureux, Elodie Boisselier
Medicinal Research Reviews. 2019; 39(1): 302
[Pubmed]  [Google Scholar] [DOI]
16 Comparison of ocular pharmacokinetics of etoposide and its nanoemulsion after subtenon administration in rabbits
Santosh Kumar Patnaik, Nabanita Halder, Bhavna Chawla, Deepti Maithani, Vasantha Thavaraj, Nihar Ranjan Biswas, Thirumurthy Velpandian
Journal of Basic and Clinical Physiology and Pharmacology. 2019; 30(5)
[Pubmed]  [Google Scholar] [DOI]
17 9.4T and 17.6T MRI of Retinoblastoma: Ex Vivo evaluation of microstructural anatomy and disease extent compared with histopathology
Marcus C. de Jong, Pim de Graaf, Petra J.W. Pouwels, Jan-Willem Beenakker, Robin W. Jansen, Jeroen J.G. Geurts, Annette C. Moll, Jonas A. Castelijns, Paul van der Valk, Louise van der Weerd
Journal of Magnetic Resonance Imaging. 2018; 47(6): 1487
[Pubmed]  [Google Scholar] [DOI]


Read this article